Abstract

The objectives of this review were once to understand the roles of the epigenetics mechanism in different types of diabetes, obesity, overweight, and cardiovascular disease. Epigenetics represents a phenomenon of change heritable phenotypic expression of genetic records taking place except changes in DNA sequence. Epigenetic modifications can have an impact on a whole of metabolic disease with the aid of specific alteration of candidate genes based totally on the change of the target genes. In this review, I summarized the new findings in DNA methylation, histone modifications in each type of diabetes (type 1 and type 2), obesity, overweight, and cardiovascular disease. The involvement of histone alterations and DNA methylation in the development of metabolic diseases is now widely accepted recently many novel genes have been demonstrated that has roles in diabetes pathway and it can be used for detection prediabetic; however Over the modern-day years, mass spectrometry-based proteomics techniques positioned and mapped one-of a kind range of histone modifications linking obesity and metabolic diseases. The main point of these changes is rapidly growing; however, their points and roles in obesity are no longer properly understood in obesity. Furthermore, epigenetic seen in cardiovascular treatment revealed a massive quantity of modifications affecting the improvement and development of cardiovascular disease. In addition, epigenetics are moreover involved in cardiovascular risk factors such as smoking. The aberrant epigenetic mechanisms that make a contribution to cardiovascular disease.

Highlights

  • Eukaryotic genomes are packaged in the two types of chromatin: Gene-rich which is called euchromatin and genetically inactive which is called heterochromatin

  • We hypothesized that H3 lysine-9 trimethylation (H3K9me3), a key repressive and steady epigenetic chromatin mark can be involved in metabolic memory [28]. chromatin immune precipitation linked to promoter tiling arrays to profile H3 lysine-9 acetylation (H3K9Ac), H3 lysine-4 tri methylation (H3K4Me3), and H3K9Me2 in blood monocytes and lymphocytes bought from 30 DCCT traditional cure group topics versus 30 DCCT intensive therapy

  • Nucleosome spacing determines chromatin structure, which can be widely divided into heterochromatin and euchromatin two Chromatin shape and gene accessibility to transcriptional machinery are regulated through modifications to both DNA and histone tails [48]

Read more

Summary

Introduction

Eukaryotic genomes are packaged in the two types of chromatin: Gene-rich which is called euchromatin and genetically inactive which is called heterochromatin. The epigenome consists of DNA methylation, histone modifications, and RNA-mediated processes, and disruption of this stability may cause numerous pathologies and make contributions to weight problems and type 2 diabetes (T2D) [11]. Cardiovascular disease is the main reasons of morbidity and loss of life in the Western society, accounting for a tremendous percentage of health care costs. This disease share frequent danger factor, together with obesity, lipid oxidation toxicity and low-grade inflammation, and they coexist in a super wide variety of patients [12].

AIMS Genetics
Characteritics of metabolic syndrome
Epigenetic in type 1 of diabetes
Epigenetic mechanisms in type 2 of diabetes
Novel candidate gene in diabetes
Chromatin modification in diabetes
Genes related to the overweight and obesity
Roles microRNAs obesity and histone alteration
Link between cardiovascular disease and epigenetics
Findings
10. Histone alteration cardiovascular disease
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call